Atrys Health (BME: ATRY), a Spanish company that provides precision medical diagnosis and treatment services and a pioneer in the fields of telemedicine and next-generation radiotherapy, has announced the acceptance of its acquisition offer for Aspy (BME: AGS).
The formalization of the transaction was conditional on its acceptance by the holders of 90% of Aspy's capital stock, provided that 85% of Aspy's shareholders attended the exchange. Thus, almost two weeks before the end of the acceptance period, the offer has been accepted by 92.06% and in addition, 91.58% have opted for the formula of exchanging their shares for Atrys shares.
After exceeding these thresholds, and once the acceptance period for the takeover bid ends on May 6, Atrys will definitively communicate the total number of securities that have accepted the offer.
The Atrys Group resulting from this operation will exceed the threshold of 170 million in turnover, its market capitalization will be around 600 million euros and it will have more than 2,000 employees and a network of 234 branch offices and associated centers distributed throughout Spain.
The company will not only lead the field of telemedicine in the Spanish language worldwide and will be one of the leaders in state-of-the-art radiotherapy at the European level, but it will also position itself as one of the three largest players in the risk prevention sector labor in Spain. The combination of both businesses will provide the Group with a great capacity for growth in the field of teleconsultation and its applications, among which the monitoring of chronic patients and its various applications in each of the medical specialties stand out.
In the words of Santiago de Torres, Chairman of Atrys, “having exceeded the acceptance threshold for the takeover bid is a great success, and we are especially proud of the high percentage of Aspy shareholders who have opted for the exchange: a real guarantee at the new stage that we will start once the operation is completed. The resulting company will be a new Atrys that will nevertheless preserve the essence and strategic direction of the project, but that will benefit from the great capillarity that the network of Aspy branches will provide us and for the opportunity to offer through it our services for medical diagnosis of pathological anatomy, molecular pathology and genetics ”.
cloud technology axon
THE WISE SEEKER S.L.es una start-up fundada en 2018 por profesionales ...
